Are Things Looking Up For Avid Bioservices Inc (NASDAQ: CDMO)?

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Stocks Info

The company is listed on the NASDAQ and operates within the Biotechnology industry segment. The current market capitalization of Avid Bioservices Inc is $550.37M. A total of 1.01 million shares were traded on the day, compared to an average of 1.41M shares.

In the most recent transaction, Green Nicholas Stewart sold 11,762 shares of CDMO for 7.40 per share on Apr 30 ’24. After the transaction, the President & CEO now owns 203,606 company shares. In a previous transaction on Apr 30 ’24, Hart Daniel R sold 2,826 shares at 7.40 per share. CDMO shares that Chief Financial Officer owns now total 82,221.

Among the insiders who sold shares, Ziebell Mark R disposed of 1,643 shares on Apr 30 ’24 at a per-share price of $7.40. This resulted in the V. P., General Counsel holding 64,834 shares of CDMO after the transaction. In another insider transaction, Kwietniak Matthew R. sold 1,233 shares at $7.40 per share on Apr 30 ’24. Company shares held by the Chief Commercial Officer now total 21,797.

It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, CDMO has a high of $18.65 and a low of $4.07.

As of this writing, CDMO has an earnings estimate of -$0.04 per share for the current quarter. EPS was calculated based on a consensus of 4.0 estimates, with a high estimate of -$0.03 per share and a lower estimate of -$0.05. The company reported an EPS of $0 in the last quarter

Balance Sheet Annually/Quarterly

An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. CDMO’s latest balance sheet shows that the firm has $126.17M in Cash & Short Term Investments as of fiscal 2022. There were $182.53M in debt and $75.76M in liabilities at the time. Its Book Value Per Share was $2.84, while its Total Shareholder’s Equity was $174.53M.

Analysts Opinion

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CDMO is Buy with a score of 4.40.

Most Popular

Related Posts